The impact of switching to polymerase chain reaction for the diagnosis of Chlamydia trachomatis infections in women

Canadian Journal of Public Health

Volumn 94, Issue 3, 2003, Pages 229-232

  Forward, Kevin R ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA BASE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MEDICAL INFORMATION; MEDICAL RECORD; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 0037675858     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03405072     Document Type: Article

References (16)

1. Martin K, Wu Z. Contraceptive use in Canada: 1984-1995. Fam Plann Perspect 2000;32:65-73.
2. Santelli JS, Lindberg LD, Abma J, McNeely CS, Resnick M. Adolescent sexual behavior: Estimates and trends from four nationally representative surveys. Fam Plann Perspect 2000;32:156-65, 194.
3. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997;10:160-84.
4. Bass CA, Jungkind DL, Silverman NS, Bondi JM. Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens. J Clin Microbiol 1993;31:2648-53.
5. Bauwens JE, Clark AM, Loeffelholz MJ, Herman SA, Stamm WE. Diagnosis of Chlamydia trachomatis urethritis in men by polymerase chain reaction assay of first-catch urine. J Clin Microbiol 1993;31:3013-16.
6. Bauwens JE, Clerk AM, Stamm WE. Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay. J Clin Microbiol 1993;31:3023-27.
7. Chernesky MA, Jang D, Lee H, Burczak JD, Hu H, Sellors J, et al. Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction. J Clin Microbiol 1994;32:2682-85.
8. de Barbeyrac B, Pellet I, Dutilh B, Bebear C, Dumon B, Geniaux M. Evaluation of the Amplicor Chlamydia trachomatis test versus culture in genital samples in various prevalence populations. Genitourin Med 1994;70:162-66.
9. Jaschek G, Gaydos CA, Welsh LE, Quinn TC, Mahony JB, Luinstra KE, et al. Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J Clin Microbiol 1993;31:1209-12.
10. Skulnick M, Chua R, Simor AE, Low DE, Khosid HE, Fraser S, et al. Use of the polymerase chain reaction for the detection of Chlamydia trachomatis from endocervical and urine specimens in an asymptomatic low-prevalence population of women. Diagn Microbiol Infect Dis 1994;20:195-201.
11. Scoular A, McCartney R, Kinn S, Carr S, Walker A. The 'real-world' impact of improved diagnostic techniques for Chlamydia trachomatis infection in Glasgow. Commun Dis Public Health 2001;4:200-4.
12. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75:3-17.
13. Rein DB, Kassler WJ, Irwin KL, Rabiee L. Direct medical cost of pelvic inflammatory disease and its sequelae: Decreasing, but still substantial. Obstet Gynecol 2000;95:397-402.
14. Goeree R, Gully P. The burden of chlamydial and gonococcal infection in Canada. In: Royal Commission on New Reproductive Technologies. Prevention of Infertility. Ottawa, ON: Minister of Supply and Services Canada, 1993;29-76.
15. Welte R, Kretzschmar M, Leidl R, van den Hoek A, Jager JC, Postma MJ. Cost-effectiveness of screening programs for Chlamydia trachomatis: A population-based dynamic approach. Sex Transm Dis 2000;27:518-29.
16. Anonymous. Reported Genital Chlamydia Cases and Rates in Canada by Province and Sex, 1991-2000, 2001; STD tables. Available on-line at: http://www.hc-sc.gc.ca/hpb/lcdc/bah/stddata0301/ (Access date July 9, 2002)